ArticleDiscover oncology2026

miR-325 serves as a prognostic biomarker and regulates tumor progression by targeting ARRDC3 in ovarian cancer.

Huixian Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.